References
- 1. Bailey S.R., Adair H.S., Reinemeyer C.R., Morgan S.J., Brooks A.C., Longhofer S.L., Elliott J.: Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet Immunol Immunopathol 2009, 129, 167–173.
- 2. Belknap J.K.: Black walnut extract: an inflammatory model. Vet Clin North Am Equine Pract 2010, 26, 95–101.
- 3. Brooks A.C., Menzies-Gow N.J., Wheeler-Jones C., Bailey S.R., Cunningham F.M., Elliott J.: Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production. Inflamm Res 2007, 56, 154–161.
- 4. Collins S.N., van Eps A.W., Pollitt C.C., Kuwano A.: The lamellar wedge. Vet Clin North Am Equine Pract 2010, 26, 179–195.
- 5. Antonella D., Rosa D., Michele Q., Vittorio M., Porzia C., Angelo P., Vito M.G., Cosimo D.G., Gennaro G.C., Eufemia S., Rosanna M., Antonia B., Vito F.: Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization. Clin Biochem 2013, 47, 184–190.
- 6. De Laat M.A., Clement C.K., McGowan C.M., Sillence M.N., Pollitt C.C., Lacombe V.A.: Toll-like receptor and pro-inflammatory cytokine expression during prolonged hyperinsulinaemia in horses: Implications for laminitis. Vet Immunol Immunopathol 2014, 157, 78–86.
- 7. De Laat M.A., Kyaw-Tanner M.T., Nourian A.R., McGowan C.M., Sillence M.N., Pollitt C.C.: The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity. Vet Immunol Immunopathol 2011, 140, 275–281.
- 8. De Laat M.A., Patterson-Kane J.C., Pollitt C.C., Sillence M.N., McGowan C.M.: Histological and morphometric lesions in the pre-clinical, developmental phase of insulin-induced laminitis in Standardbred horses. Vet J 2013, 195, 305–312.
- 9. Donnini S., Morbidelli L., Taraboletti G., Ziche M.: ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. Life Sci 2004, 74, 2975–2985.
- 10. Dugdale A.H., Grove-White D., Curtis G.C., Harris P.A., Argo C.M.: Body condition scoring as a predictor of body fat in horses and ponies. Vet J 2012, 194, 173–178.
- 11. Eades S.C.: Overview of current laminitis research. Vet Clin North Am Equine Pract 2010, 26, 51–63.
- 12. Eps A.V., Pollitt C.C.: Equine laminitis induced with oligofructose. Equine Vet J 2006, 38, 203–208.
- 13. Howard E.W., Crider B.J., Updike D.L., Bullen E.C., Parks E.E., Haaksma C.J., Sherry D.M., Tomasek J.J.: MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype. Exp Cell Res 2012, 318, 1542-1553.
- 14. Loftus J.P., Johnson P.J., Belknap J.K, Pettigrew A, Black S.J.: Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol 2009, 129, 221-230.
- 15. Longland A.C, Byrd B.M.: Pasture nonstructural carbohydrates and equine laminitis. J Nutr 2006, 136, 2099-2102.
- 16. Menzies-Gow N.J., Bailey S.R, Katz L.M., Marr CM., Elliott J.: Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet J 2004, 36, 273-278.
- 17. Moore J.N., Garner H.E., Berg J.N., Sprouse R.F.: Intracecal endotoxin and lactate during the onset of equine laminitis: a preliminary report. Am J Vet Res 1979, 40, 722-723.
- 18. Morris D.D.: Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991, 5, 167-181.
- 19. Pollitt CC: The anatomy and physiology of the suspensory apparatus of the distal phalanx. Vet Clin North Am Equine Pract 2010, 26, 29-49.
- 20. Pollitt CC, Visser M.B.: Carbohydrate alimentary overload laminitis. Vet Clin North Am Equine Pract 2010, 26, 65-78.
- 21. Pons M, Cousins S.W., Alcazar O, Striker G.E, Marin-Castaño M.E.: Angiotensin II-Induced MMP-2 activity and MMP-14 and Basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol 2011, 178, 2665-2681.
- 22. Radziwon-Balicka A, Ramer C, Moncada de la Rosa C., Zielnik-Drabik B, Jurasz P.: Angiostatin inhibits endothelial MMP-2 and MMP-14 expression: a hypoxia specific mechanism of action. Vascul Pharmacol 2013, 58, 280-291.
- 23. Stewart AJ, Pettigrew A, Cochran A.M, Belknap J.K.: Indices of inflammation in the lung and liver in the early stages of the black walnut extract model of equine laminitis. Vet Immunol Immunopathol 2009, 129, 254-260.
- 24. Tadros E.M, Frank N, Horohov D.W.: Inflammatory cytokine gene expression in blood during the development of oligofructose-induced laminitis in horses. J Equine Vet Sci 2013, 33, 802-808.
- 25. Taylor D, Hood D.M, Wagner I.P.: Short-term effect of therapeutic shoeing on severity of lameness in horses with chronic laminitis. Am J Vet Res 2002, 63, 1629-1633.
- 26. Toth F, Frank N, Chameroy K.A, Boston R.C.: Effects of endotoxaemia and carbohydrate overload on glucose and insulin dynamics and the development of laminitis in horses. Equine Vet J 2009, 41, 852-858.
- 27. Visser M.B, Pollitt CC: Lamellar leukocyte infiltration and involvement of IL-6 during oligofructose-induced equine laminitis development. Vet Immunol Immunopathol 2011, 144, 120-128.
- 28. Wang L, Pawlak E.A, Johnson P.J, Belknap J.K, Alfandari D, Black S.J.: Expression and activity of metalloproteinases in the digital laminae of horses with starch gruel-induced laminitis. J Equine Vet Sci 2011, 31, 566.
- 29. Wilkinson J.M, Davidson R.K, Swingler T.E, Jones E.R, Corps A.N, Johnston P, Riley G.P, Chojnowski AJ, Clark I.M.: MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction. Biochim Biophys Acta 2012, 1822, 897-905.
- 30. Yang J, Wang G, Gao C, Shao G, Kang N.: Effects of hyperbaric oxygen on MMP-2 and MMP-9 expression and spinal cord edema after spinal cord injury. Life Sci 2013, 93, 1033-1038.